When: MACD crosses above signal line with both MACD and signal line above zero

Then: Second confirmation signal for potential re-engagement

When: RSI sustained above 55

Then: Third confirmation signal for potential re-engagement

Trim 15-20% versus benchmark weight; maintain $510 stop loss; do not initiate new positions; hold freed capital in cash equivalents or rotate to higher-conviction defense names with clearer technical and fundamental alignment.

• LMT dividend yield of 2.6% with projected growth to ~2.8% next year and ~3.0% the following year, averaging 7-8% annual growth over the past decade—exceeds 4.5% risk-free Treasury over 3-5 year horizon before capital appreciation
• 0.10 beta provides defensive portfolio ballast; negative correlation to consumer cyclicals becomes more valuable in hawkish Fed/rising rate regimes
• 200 SMA has risen from ~$464 in January to ~$553 today—structurally rising long-term trend; price meeting rising average from above is a basing pattern, not a topping pattern
• MACD histogram narrowed from -6 at September 4 trough to -1.52 currently—downside momentum exhausting, not a coiled spring for further decline
• RSI reconstructed from 34 to 44 with a higher low (34 vs prior 40-43 area) as price made slightly lower low—bullish RSI divergence forming
• Space weapons catalyst September 15 non-reaction reflects institutional digestion over weeks, not exhausted marginal buyers; multi-year revenue story tied to budget appropriations
• Q2 2025 results: $20.06 billion revenue, $2.48 billion operating income, $342 million net income, $7.94 EPS—highest revenue and EPS in five-quarter window
• Forward P/E of 16.4 vs TTM P/E of 19.8 implies ~21% earnings growth; PEG ratio of 1.01 is not expensive for a quality compounder
• Aggressive 30-50% trim forfeits ~$16-30 per share of upside if LMT reclaims $553 toward $581 on a bullish resolution
• Q4 government shutdown risk is real but DoD essential functions continue during CRs; F-35 TR-3 and Block 4 concerns are perennial headline risks the program has weathered
• Structural defense spending story tied to NATO 2-3% GDP minimums, Indo-Pacific posture, and Western munitions stockpile rebuilding—not solely dependent on active conflicts
• $510 stop aligns with Bollinger lower band and April structural low—confirmation level for more aggressive reduction

→ vs aggressive: Bond substitution framing is backwards—equity dividend is not a fixed coupon; LMT dividend has grown for 20+ consecutive years averaging 7-8% annually, which exceeds 4.5% Treasury yield over 3-5 year horizon before capital appreciation

→ vs aggressive: Bond substitution argument only works if assuming equity is held purely for income; LMT is held for portfolio ballast characteristics including 0.10 beta and negative correlation to cyclicals, which become more valuable in hawkish Fed regime

→ vs aggressive: 50/200 SMA convergence at $552-553 is mischaracterized as death cross precursor—200 SMA is structurally rising (from $464 to $553), making this a basing pattern meeting a rising average, not a topping pattern

→ vs aggressive: MACD below zero is a momentum readout not a trend readout; histogram narrowing from -6 to -1.52 shows downside momentum exhausting, not a coiled spring building for further decline

→ vs aggressive: RSI 34-44 reconstruction shows higher low (34 vs prior 40-43 area) as price made lower low—bullish divergence, not a neutral return to oversold

→ vs aggressive: Space weapons one-day non-reaction is noise elevated to signal; institutional accumulation for multi-year revenue stories unfolds over weeks, not single sessions

→ vs aggressive: Q2 2026 recovery framed as merely returning to baseline ignores that $342M net income in anomalous Q2 reflects real fixed-cost deleveraging; 16.4x forward P/E with 21% implied growth and 1.01 PEG is reasonably valued, not dressed-up transformation

→ vs aggressive: Trimming 30-50% now locks in current uncertainty as if it were certainty; selling mid-range at $555-537 leaves approximately equal probability of being right or wrong on direction

→ vs neutral: Stop at $510 is appropriate, but trimming 30-50% before that confirmation level is preemptive on a quality name—the opportunity cost of being wrong on a reversion to $581 is significant on a $124B market cap name

Trim approximately 20-25% of existing position versus benchmark weight now at 555 entry (market currently at 537.25); pre-commit to additional 10-15% reduction if price loses 525 on daily close with volume confirmation; consider pair trade structure long LMT/short weaker defense names; maintain 510 stop-loss and 553 re-entry framework; do not initiate new positions at current levels.

• Hawkish Fed regime change is the most important new variable: 4.5%+ risk-free rate against 2.6% dividend yield creates real multiple compression risk
• Forward earnings estimates around $32.75 with 16.4 forward P/E and PEG of 1.01 represent defensible, not stretched, valuation
• MACD histogram narrowing from negative 6 to negative 1.5 indicates stabilization; RSI higher low at 34 vs prior pivot is modest bullish divergence
• Rising 200 SMA from 464 to 553 is constructive but price currently sits 15 dollars below it—a failure to hold rather than successful test
• LMT down 1.3% vs LHX down 18.9% and RKLB down 39% suggests active institutional bid, not marginal buyer exhaustion
• Tail risks include CR funding gaps affecting forward guidance, F-35 Block 4 cost growth flagged in multiple GAO reports, and geopolitical de-escalation compressing urgency premium
• Current market at 537.25 provides better technical positioning on trim than 555 entry (closer to lower Bollinger band at 510 and September low at 525)
• 510 stop-loss correctly aligned with lower Bollinger band, April structural low, and roughly 2-2.5 ATR distances
• Re-entry framework: reclaim 553 on volume above 20% of 20-day average, MACD cross above signal with both above zero, RSI sustained above 55

→ vs aggressive: The 'failed catalyst means priced in' argument is too mechanical; institutional flows on multi-year appropriations don't move in single sessions, and LMT's relative outperformance contradicts the marginal buyer exhaustion thesis

→ vs aggressive: The 'last leg of rotation before everything reprices' framing is essentially a fear call without a concrete trigger; defense appropriations are expanding, NATO is increasing minimums, and Pentagon confirmed space weapons

→ vs aggressive: Dismissing Q2 2025 as anomalous but then ignoring the implied forward multiple of 16.4 is inconsistent; if Q2 2026 is the run-rate, the valuation is defensible

→ vs conservative: The opportunity cost framing of 16-30 dollars per share is one-sided; the symmetric downside is 25-32 dollar stop distance from 555 entry, creating asymmetric exposure profile in the wrong direction

→ vs conservative: The 'rising 200 SMA means uptrend intact' framing misses that price is currently below the rising average; that's a failure to hold, not a healthy test

→ vs conservative: Essential DoD function continuity during shutdowns doesn't eliminate new-contract and incremental funding risk affecting forward guidance path

→ vs conservative: Minimizing geopolitical de-escalation as 'single diplomatic event' understates how quickly the urgency premium can compress—defense sector multiple expansion since Ukraine invasion is meaningful and reversible